spacer
home > ebr > spring 2002 > quebec leads the way in canada's biotechnology sector
PUBLICATIONS
European Biopharmaceutical Review

Quebec Leads the Way in Canada's Biotechnology Sector

The biotechnology sector is already well entrenched in Canada and in the Province of Quebec. Its significance in the nation's economy is no longer an issue. Quebec's potential for growth elicits even more hope, as well as intense rivalries. However, although many numbers abound, it is often difficult to draw an accurate statistical portrait of the true situation.

A Few More Specifics

A survey undertaken by Statistics Canada in 1999 on the operations and development of the biotechnology sector measured several industry parameters. The data collected constitutes a reliable indicator of the recent and anticipated evolution of the biotech industry.

Beyond the increase in the number of companies, a considerable amount of data testify to the sector's sustained growth that might even be accelerating. Revenue from biotechnology activities in Canada jumped by 71.6 per cent from 1997 to 1999. In the Province of Quebec, the increase was even more spectacular, soaring more than 147.3 per cent over the same two-year period. This dramatic growth in revenue is a clear sign that the industry has attained a certain maturity. Worldwide, Canadian sales account for less than 5 per cent. However, that figure could double between now and 2005.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Perry Niro, Executive Director at BIOQuebec

A graduate of the University of Montreal, with a Master's degree in Political Science and training in public relations, Perry Niro began his career in 1987 at the Order of Chartered Accountants of Quebec as a Public Affairs Advisor.
In 1990 he was appointed Political Advisor within the Quebec Environment Minister's Office. In 1993 he founded Envirotech magazine which he ran until 1997.
After a stint as Public Affairs Director of the Quebec Industrial Research Association (ADRIQ), he was appointed Executive Director of BIOQuebec - the Quebec Bio-industries Association - in January 2000.

spacer
Perry Niro
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Breakthrough in the global battle against polio: AJ Vaccines granted WHO prequalification for new polio vaccine

Despite ongoing concerted efforts to eradicate polio, it appears to be on the rise again with more cases registered in 2019 than 2018. Looking ahead, AJ Vaccines’ dose sparing technology provides a significant opportunity to expand supply, with the potential to deliver up to 100 million doses over the five-year period 2020-2024 to help meet the currently unmet global demand for inactivated polio vaccines.
More info >>

White Papers

EU GDP Guidelines: Implications for Shipping Clinical Materials into the European Market

PCI Pharma Services

Recently, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) opened an investigation into a patient complaint of mold on paracetamol (acetaminophen) tablets (1). It discovered the product was shipped by sea from India to multiple companies in the UK at temperatures reaching up to 60 degrees Celsius. Labeling for paracetamol tablets typically states they should be kept below 30 degrees Celsius. In addition, MHRA discovered the humidity levels exceeded 80 percent during shipping, which is too high for the packaging that was used.
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement